Medicamen Biotech Limited (BOM:531146)
India · Delayed Price · Currency is INR 271.30
+0.45 (0.17%)
At close: May 26, 2026
Medicamen Biotech Market Cap
Medicamen Biotech has a market cap or net worth of 3.6 billion as of May 27, 2026. Its market cap has decreased by -33.54% in one year.
Market Cap
3.60B
Enterprise Value
3.76B
Revenue
1.72B
Ranking
n/a
PE Ratio
48.44
Stock Price
271.30
Market Cap Chart
Since January 12, 2005, Medicamen Biotech's market cap has increased from 108.49M to 3.60B, an increase of 3,217.27%. That is a compound annual growth rate of 17.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 3.60B | -22.04% |
| Dec 31, 2025 | 4.62B | -28.94% |
| Dec 31, 2024 | 6.50B | -14.77% |
| Dec 29, 2023 | 7.62B | -27.09% |
| Dec 30, 2022 | 10.45B | -3.50% |
| Dec 31, 2021 | 10.83B | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jenburkt Pharmaceuticals | 5.11B |
| Amanta Healthcare | 4.58B |
| Albert David | 4.08B |
| Medico Remedies | 3.99B |
| Trident Lifeline | 2.98B |
| Gennex Laboratories | 2.94B |
| Sat Kartar Life | 2.88B |
| Kerala Ayurveda | 2.68B |